Implantica Investor Relations Material
Latest events
Q1 2025
Implantica
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Implantica
Access all reports
Implantica AG with headquarters in Horw/Luzern (Switzerland) is a company developing and distributing innovative solutions for reconstructive surgery. The company’s range of products includes implants based on the unique Zoladex® technology, which is used in a wide variety of applications such as industrial implants, biodegradable drug carriers and scaffolds. In addition Implantica provides best-in-class synthetic meshes for use in hernia repair procedures.
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
IMP
Country
🇸🇪 Sweden